vs

Side-by-side financial comparison of Medirom Healthcare Technologies Inc. (MRM) and TRANSCONTINENTAL REALTY INVESTORS INC (TCI). Click either name above to swap in a different company.

Medirom Healthcare Technologies Inc. is the larger business by last-quarter revenue ($21.1M vs $12.1M, roughly 1.7× TRANSCONTINENTAL REALTY INVESTORS INC). TRANSCONTINENTAL REALTY INVESTORS INC runs the higher net margin — 68.8% vs -21.3%, a 90.1% gap on every dollar of revenue.

Medirom Healthcare Technologies Inc. develops and delivers integrated digital health and remote patient monitoring solutions targeted at chronic disease management, post-operative care, and senior health support. It serves healthcare providers, insurance payers, and institutional care partners across key markets in North America and the Asia-Pacific region, prioritizing accessible, data-driven care to improve patient outcomes.

Transcontinental Realty Investors Inc. (TCI) is a U.S.-based real estate investment firm that owns, operates and develops a diversified portfolio of residential, commercial and mixed-use properties across core U.S. regional markets. It pursues long-term value growth via strategic property acquisitions, efficient asset management and tailored leasing solutions for individual and business tenants.

MRM vs TCI — Head-to-Head

Bigger by revenue
MRM
MRM
1.7× larger
MRM
$21.1M
$12.1M
TCI
Higher net margin
TCI
TCI
90.1% more per $
TCI
68.8%
-21.3%
MRM

Income Statement — Q2 FY2025 vs Q4 FY2025

Metric
MRM
MRM
TCI
TCI
Revenue
$21.1M
$12.1M
Net Profit
$-4.5M
$8.3M
Gross Margin
10.8%
Operating Margin
-28.5%
-28.9%
Net Margin
-21.3%
68.8%
Revenue YoY
2.3%
Net Profit YoY
7577.8%
EPS (diluted)
$0.97

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MRM
MRM
TCI
TCI
Q4 25
$12.1M
Q3 25
$12.8M
Q2 25
$21.1M
$12.2M
Q1 25
$12.0M
Q4 24
$11.8M
Q3 24
$11.6M
Q2 24
$11.8M
Q1 24
$11.9M
Net Profit
MRM
MRM
TCI
TCI
Q4 25
$8.3M
Q3 25
$724.0K
Q2 25
$-4.5M
$169.0K
Q1 25
$4.6M
Q4 24
$108.0K
Q3 24
$1.7M
Q2 24
$1.5M
Q1 24
$2.5M
Gross Margin
MRM
MRM
TCI
TCI
Q4 25
Q3 25
Q2 25
10.8%
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Operating Margin
MRM
MRM
TCI
TCI
Q4 25
-28.9%
Q3 25
-10.9%
Q2 25
-28.5%
-6.8%
Q1 25
-5.3%
Q4 24
-14.3%
Q3 24
-14.4%
Q2 24
-9.2%
Q1 24
-11.2%
Net Margin
MRM
MRM
TCI
TCI
Q4 25
68.8%
Q3 25
5.6%
Q2 25
-21.3%
1.4%
Q1 25
38.5%
Q4 24
0.9%
Q3 24
14.7%
Q2 24
12.7%
Q1 24
21.4%
EPS (diluted)
MRM
MRM
TCI
TCI
Q4 25
$0.97
Q3 25
$0.08
Q2 25
$0.02
Q1 25
$0.53
Q4 24
$0.01
Q3 24
$0.20
Q2 24
$0.17
Q1 24
$0.30

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MRM
MRM
TCI
TCI
Cash + ST InvestmentsLiquidity on hand
$252.3K
$89.0M
Total DebtLower is stronger
$8.8M
$210.8M
Stockholders' EquityBook value
$1.6M
$846.7M
Total Assets
$52.0M
$1.1B
Debt / EquityLower = less leverage
5.55×
0.25×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MRM
MRM
TCI
TCI
Q4 25
$89.0M
Q3 25
$82.7M
Q2 25
$252.3K
$73.5M
Q1 25
$88.6M
Q4 24
$99.7M
Q3 24
$131.6M
Q2 24
$127.5M
Q1 24
$130.8M
Total Debt
MRM
MRM
TCI
TCI
Q4 25
$210.8M
Q3 25
$223.5M
Q2 25
$8.8M
$212.4M
Q1 25
$198.2M
Q4 24
$181.9M
Q3 24
$180.3M
Q2 24
$177.4M
Q1 24
$178.3M
Stockholders' Equity
MRM
MRM
TCI
TCI
Q4 25
$846.7M
Q3 25
$838.4M
Q2 25
$1.6M
$837.7M
Q1 25
$837.3M
Q4 24
$832.3M
Q3 24
$832.2M
Q2 24
$830.4M
Q1 24
$828.9M
Total Assets
MRM
MRM
TCI
TCI
Q4 25
$1.1B
Q3 25
$1.1B
Q2 25
$52.0M
$1.1B
Q1 25
$1.1B
Q4 24
$1.1B
Q3 24
$1.1B
Q2 24
$1.0B
Q1 24
$1.0B
Debt / Equity
MRM
MRM
TCI
TCI
Q4 25
0.25×
Q3 25
0.27×
Q2 25
5.55×
0.25×
Q1 25
0.24×
Q4 24
0.22×
Q3 24
0.22×
Q2 24
0.21×
Q1 24
0.22×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MRM
MRM
TCI
TCI
Operating Cash FlowLast quarter
$-2.3K
$-2.9M
Free Cash FlowOCF − Capex
$-2.4K
FCF MarginFCF / Revenue
-0.0%
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
-0.35×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MRM
MRM
TCI
TCI
Q4 25
$-2.9M
Q3 25
$8.2M
Q2 25
$-2.3K
$-2.9M
Q1 25
$-7.4M
Q4 24
$1.3M
Q3 24
$13.7M
Q2 24
$-511.0K
Q1 24
$3.9M
Free Cash Flow
MRM
MRM
TCI
TCI
Q4 25
Q3 25
Q2 25
$-2.4K
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
FCF Margin
MRM
MRM
TCI
TCI
Q4 25
Q3 25
Q2 25
-0.0%
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Capex Intensity
MRM
MRM
TCI
TCI
Q4 25
Q3 25
Q2 25
0.0%
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Cash Conversion
MRM
MRM
TCI
TCI
Q4 25
-0.35×
Q3 25
11.28×
Q2 25
-17.24×
Q1 25
-1.61×
Q4 24
12.13×
Q3 24
8.03×
Q2 24
-0.34×
Q1 24
1.52×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MRM
MRM

Professional services expense$20.0M95%
Other$1.1M5%

TCI
TCI

Segment breakdown not available.

Related Comparisons